ALCJCrossjectALCJ info
$2.63info0.64%24h
Global rank21459
Market cap$96.24M
Change 7d4.19%
YTD Performance-52.61%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Crossject (ALCJ) Stock Overview

    Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, a needle-free device for patient-side management disorders self-injectables. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. The company was founded in 2001 and is based in Dijon, France.

    ALCJ Stock Information

    Symbol
    ALCJ
    Address
    6 Rue Pauline KergomardDijon, 21000France
    Founded
    -
    Trading hours
    -
    Website
    https://www.crossject.com
    Country
    🇫🇷 France
    Phone Number
    33 3 80 54 98 50

    Crossject (ALCJ) Price Chart

    -
    Value:-

    Crossject Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.63
    N/A
    Market Cap
    $96.24M
    N/A
    Shares Outstanding
    36.61M
    N/A
    Employees
    110.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org